A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Clinical trial NCT02592317 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02592317
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-12
- Primary completion
- 2016-11-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.